First Trust Advisors
SRNE

First Trust Advisors’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

First Trust Advisors’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-282,917
Closed -$2.16M – 2634
2021
Q3 		$2.16M Buy
282,917
+214,194
+312% +$1.82M ﹤0.01% 1750
2021
Q2 		$666K Buy
+68,723
New +$547K ﹤0.01% 2179
2021
Q1 		– Sell
-177,086
Closed -$1.21M – 2481
2020
Q4 		$1.21M Buy
+177,086
New +$1.42M ﹤0.01% 1818

Other funds holding SRNE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

First Trust Advisors's SRNE Position: Q4 2021 in Review

First Trust Advisors sold out of Sorrento Therapeutics, Inc. (SRNE) in Q4 2021, closing a stake of 282,917 shares — an estimated $2.16M sold.

First Trust Advisors first reported a position in SRNE in Q4 2020 and held it in 3 quarters. The position peaked at $2.16M in Q3 2021. 234 funds tracked by Wall St. Rank hold SRNE as of Q4 2021.

  • First Trust Advisors reported no remaining Sorrento Therapeutics, Inc. position as of Q4 2021 after selling out during the quarter.
  • First Trust Advisors sold 282,917 Sorrento Therapeutics, Inc. shares in Q4 2021, an estimated $2.16M.
  • First Trust Advisors first reported a position in Sorrento Therapeutics, Inc. in Q4 2020 and held it in 3 quarters.
  • First Trust Advisors's Sorrento Therapeutics, Inc. position peaked at $2.16M in Q3 2021.
  • 234 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q4 2021.

Based on First Trust Advisors's 13F filing for Q4 2021, filed 8 Feb 2022.